会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • DIFFERENTIAL HEMOLYSIS OF A WHOLE BLOOD SAMPLE
    • 全血样品的差异分析
    • US20090253210A1
    • 2009-10-08
    • US12328890
    • 2008-12-05
    • Uwe KoboldThomas DuelfferRupert HerrmannHerbert von der Eltz
    • Uwe KoboldThomas DuelfferRupert HerrmannHerbert von der Eltz
    • G01N33/48H01J49/00
    • G01N30/06G01N30/603G01N30/7233G01N33/5002G01N2030/027Y10T436/24Y10T436/25
    • The invention relates to a method for differentially hemolyzing whole blood. It discloses method for detecting an analyte in a liquid sample known or suspected to comprise red blood cells and suspected or known to comprise eukaryotic cells, the method comprising the steps of processing said liquid sample with a membrane solubilizing agent under conditions appropriate to lyse cell membranes of red blood cells and at the same time not to cause precipitation of sample constituents, subjecting the processed sample to a chromatographic separation, and detecting the analyte. The differential hemolysis of red blood cells is of advantage in a method of detecting an analyte in a liquid sample that may comprise both erythrocytes as well as nucleated cells. The differential solubilization of red blood cells can be easily combined with an online detection methodology, like LC-MS, and is advantageous in the detection of many analytes, e.g. in the detection of folate or of immunosuppressive drugs, like tacrolimus or sirolimus.
    • 本发明涉及一种使全血不同溶血的方法。 它公开了用于检测已知或怀疑包含红细胞并且怀疑或已知包含真核细胞的液体样品中的分析物的方法,所述方法包括以下步骤:在适合于裂解细胞膜的条件下用膜增溶剂处理所述液体样品 的红细胞,同时不会引起样品成分沉淀,对经处理的样品进行色谱分离,并检测分析物。 在检测可能包含红细胞和有核细胞的液体样品中的分析物的方法中,红细胞的差异溶血是有利的。 红细胞的差异溶解可以容易地与诸如LC-MS的在线检测方法组合,并且在许多分析物的检测中是有利的,例如, 在检测叶酸或免疫抑制药物,如他克莫司或西罗莫司。
    • 6. 发明授权
    • Differential hemolysis of a whole blood sample
    • 全血样品的差异溶血
    • US07951598B2
    • 2011-05-31
    • US12328890
    • 2008-12-05
    • Uwe KoboldThomas DuelfferRupert HerrmannHerbert von der Eltz
    • Uwe KoboldThomas DuelfferRupert HerrmannHerbert von der Eltz
    • G01N33/48
    • G01N30/06G01N30/603G01N30/7233G01N33/5002G01N2030/027Y10T436/24Y10T436/25
    • The invention relates to a method for differentially hemolyzing whole blood. It discloses methods for detecting an analyte in a liquid sample known or suspected to contain red blood cells and suspected or known to contain eukaryotic cells, the method including the steps of processing the liquid sample with a membrane solubilizing agent under conditions appropriate to lyse cell membranes of red blood cells and at the same time not to cause precipitation of sample constituents, subjecting the processed sample to a chromatographic separation, and detecting the analyte. The differential hemolysis of red blood cells is of advantage in a method of detecting an analyte in a liquid sample that may contain both erythrocytes and nucleated cells. The differential solubilization of red blood cells can be easily combined with an online detection methodology, like LC-MS, and is advantageous in the detection of many analytes, e.g. in the detection of folate or of immunosuppressive drugs, like tacrolimus or sirolimus.
    • 本发明涉及一种使全血不同溶血的方法。 它公开了用于检测已知或怀疑含有红细胞并且怀疑或已知含有真核细胞的液体样品中的分析物的方法,该方法包括在适于裂解细胞膜的条件下用膜增溶剂处理液体样品的步骤 的红细胞,同时不会引起样品成分沉淀,对经处理的样品进行色谱分离,并检测分析物。 在检测可能含有红细胞和有核细胞的液体样品中的分析物的方法中,红细胞的差异溶血是有利的。 红细胞的差异溶解可以容易地与诸如LC-MS的在线检测方法组合,并且在许多分析物的检测中是有利的,例如, 在检测叶酸或免疫抑制药物,如他克莫司或西罗莫司。